Wikidata

(Q64720843)

English

Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension

clinical trial

In more languages

Statements

short name
SERAPHIN (English)
0 references
title
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension (English)
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belarus
0 references
Belgium
0 references
Bulgaria
0 references
Canada
0 references
Chile
0 references
Colombia
0 references
Croatia
0 references
France
0 references
Germany
0 references
Hungary
0 references
India
0 references
Israel
0 references
Italy
0 references
Malaysia
0 references
Mexico
0 references
Netherlands
0 references
Norway
0 references
Peru
0 references
Poland
0 references
Romania
0 references
Serbia
0 references
Singapore
0 references
Slovakia
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
Taiwan
0 references
Thailand
0 references
Turkey
0 references
Ukraine
0 references
United Kingdom
0 references
start time
May 2008
0 references
end time
March 2012
0 references
number of participants
742
0 references
minimum age
12 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64720843&oldid=2071659995"